Diagnostic Testing Fight Puts FDA In A Pickle

By Jeff Overley (June 6, 2014, 7:05 PM EDT) -- The U.S. Food and Drug Administration is facing pressure to let more diagnostic testing tools be used in doctors' offices, placing regulators in the middle of a feud between device manufacturers eager to boost sales and sophisticated laboratories that stand to lose business.

Debate centers on how to interpret the Clinical Laboratory Improvement Amendments of 1988, which allow in vitro diagnostics — such as devices that analyze blood or saliva — to obtain a waiver for use in doctors' offices and clinics if they are deemed to be "simple" and to pose an "insignificant risk of an erroneous result."

Last month,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!